Navigation Links
Agenus Implements Genedata End-to-End Biologics Workflow Platform for Immunotherapy R&D
Date:12/4/2019

Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced that Agenus, a clinical-stage immuno-oncology company developing therapies to fight cancer, has chosen Genedata Biologics® as a part of their antibody R&D workflow platform. Agenus will use the platform to support immunotherapy and vaccine pipeline programs across their global organization.

“Genedata Biologics was the clear choice as a backbone system to support the full diversity of our complex and rapidly evolving antibody discovery processes in the US and the UK,” said Dennis Underwood, Ph.D., VP Molecular and Information Systems at Agenus. The platform helps streamline Agenus’s growing pipeline of checkpoint-inhibitor candidates and simultaneously supports screening, engineering, expression, purification, and analytics processes for proteins and antibodies, including bispecifics and other innovative next-generation molecules.

Agenus scientists have set path-breaking records delivering new discoveries to the clinic in the past three years. The Genedata Biologics technology, in conjunction with Agenus’s Intelligent (Re)search (AIR) platform, will further augment Agenus scientists’ ability to capture, process, and interpret all large-molecule R&D data and is an important component of the Agenus collaborative data and information platform. Molecule, sample, assay and analytics data, including developability and manufacturability data, are shared between different project teams and sites. This enables systematic and transparent decision-making when selecting therapeutic candidates to be progressed through the clinical development pipeline.

“We are excited that Agenus, a leading company developing unique immune therapies for patients with cancer, has chosen Genedata Biologics as core infrastructure to support their biotherapeutics discovery processes,” said Othmar Pfannes, Ph.D., CEO of Genedata. “This collaboration also demonstrates that innovative, fast-paced biopharma companies can benefit from an integrated data capture and workflow management system. We look forward to a long and productive partnership helping Agenus increase the efficiency of their biologics discovery and development processes.”

About Genedata
Genedata transforms data into intelligence with innovative software solutions and domain-specific consulting services that automate complex, large-scale experimental processes and enable organizations to maximize the ROI in their R&D, spanning early discovery all the way to the clinic. Founded in 1997, Genedata is headquartered in Switzerland with additional offices in Germany, Japan, Singapore, the UK, and the US.
http://www.genedata.com
LinkedIn | Twitter | YouTube

Contact
Miles Fisher-Pollard
Genedata
Public Relations
Phone: +41 61 511 85 61
pr@genedata.com

Disclaimer
The statements in this press release that relate to future plans, events or performance are forward-looking statements that involve risks and uncertainties, including risks associated with uncertainties related to contract cancellations, developing risks, competitive factors, uncertainties pertaining to customer orders, demand for products and services, development of markets for the Company's products and services. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. The Company undertakes no obligation to release publicly the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

All product and service names mentioned are the trademarks of their respective companies.

Read the full story at https://www.prweb.com/releases/agenus_implements_genedata_end_to_end_biologics_workflow_platform_for_immunotherapy_r_d/prweb16759074.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related biology news :

1. IRSF announces 2013 awards and implements new Translational Program
2. Genedata Announces Aptevo Therapeutics Deploys Genedata Biologics to Streamline Cancer Immunotherapy R&D
3. Deep Learning-Based Genedata Imagence® for Automated High-Content Image Analysis Debuts at SLAS Conference
4. Genedata Licenses its Bioprocess Software Platform to Sartorius Stedim Cellca
5. Octapharma Adopts Genedata Bioprocess to Develop Next-generation Bio-manufacturing Processes
6. PrimBio Research Selects Tute as Whole Exome Analysis Provider, Creating Integrated, End-to-End Solution for Next-Generation Sequencing & Data Analysis
7. DNAnexus and QIAGEN Team Up in Education Webinar: Scaling End-to-End NGS Solutions for Clinical Diagnostics in the Cloud
8. MassBiologics receives orphan drug status from FDA for hepatitis C treatment
9. Next-Generation Biologics: R&D, Industry and Market Forecasts 2015-2025
10. Synthetic Biologics Announces Pricing of Public Offering of Common Stock and Warrants
11. Mosaic Biomedicals se une a Northern Biologics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/12/2019)... ... November 12, 2019 , ... In’Tech Medical SAS ( http://www.intech-medical.com ... creation of a Global Regulatory Affairs Department, to support Medical Device companies across ... regulatory element to any Medtech organization is more important than Research & Development, ...
(Date:11/12/2019)... ... November 12, 2019 , ... Atlantic ... purifiers, announced today that distributors voted their patented automatic and manual wipers the ... purifiers. , The most frequent maintenance task required of an ultraviolet water purifier ...
(Date:11/7/2019)... ... November 07, 2019 , ... R3 Stem Cell is now ... the rest of 2019. The code to use during checkout is FIFTYOFF and applies ... is the nation’s leader in regenerative therapies with over 12,000 successful stem cell procedures ...
Breaking Biology News(10 mins):
(Date:12/4/2019)... ... ... Bold Brahim aka Jesse, a Spanish Arabian, was 11 years old when ... medical management, his condition worsened so his owner, Diane, sought a bone scan and ... had a severe injury to his deep digital flexor tendon in his right front ...
(Date:11/27/2019)... , ... November 25, 2019 , ... ... has announced the company’s first robotic-assisted and navigated surgery in the UK. The ... (NHS) by acclaimed spine surgeons, Dr. Syed Aftab and Dr. Alexander Montgomery. The ...
(Date:11/12/2019)... ... November 12, 2019 , ... ... that they have been selected by Lantern Pharma to provided preclinical screening and ... obtain millions of data points using panels of unique and genetically edited cell ...
(Date:11/9/2019)... BOSTON (PRWEB) , ... November ... ... provider of artificial intelligence (AI)-powered technology for use in pathology research, today ... in liver biopsy samples from patients enrolled in the phase 3 selonsertib ...
Breaking Biology Technology: